Parapneumonic pleural effusion and empyema

被引:68
作者
Koegelenberg, Coenraad F. N. [1 ,2 ]
Diacon, Andreas H. [2 ,3 ]
Bolliger, Chris T. [1 ,2 ]
机构
[1] Univ Stellenbosch, Dept Med, Div Pulmonol, ZA-7505 Tygerberg, South Africa
[2] Tygerberg Acad Hosp, ZA-7505 Tygerberg, South Africa
[3] Univ Stellenbosch, Dept Biomed Sci, Div Med Physiol, ZA-7505 Tygerberg, South Africa
关键词
parapneumonic pleural effusion; empyema; fibrinolytics; thoracoscopy; thoracotomy; thoracostomy;
D O I
10.1159/000117172
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
At least 40% of all patients with pneumonia will have an associated pleural effusion, although a minority will require an intervention for a complicated parapneumonic effusion or empyema. All patients require medical management with antibiotics. Empyema and large or loculated effusions need to be formally drained, as well as parapneumonic effusions with a pH < 7.20, glucose < 3.4 mmol/l (60 mg/dl) or positive microbial stain and/or culture. Drainage is most frequently achieved with tube thoracostomy. The use of fibrinolytics remains controversial, although evidence suggests a role for the early use in complicated, loculated parapneumonic effusions and empyema, particularly in poor surgical candidates and in centres with inadequate surgical facilities. Early thoracoscopy is an alternative to thrombolytics, although its role is even less well defined than fibrinolytics. Local expertise and availability are likely to dictate the initial choice between tube thoracostomy (with or without fibrinolytics) and thoracoscopy. Open surgical intervention is sometimes required to control pleural sepsis or to restore chest mechanics. This review gives an overview of parapneumonic effusion and empyema, focusing on recent developments and controversies. Copyright (c) 2008 S. Karger AG, Basel.
引用
收藏
页码:241 / 250
页数:10
相关论文
共 58 条
[1]   Association between inflammatory mediators and the fibrinolysis system in infectious pleural effusions [J].
Alemán, C ;
Alegre, J ;
Monasterio, J ;
Segura, RM ;
Armadans, L ;
Anglés, A ;
Varela, E ;
Ruiz, E ;
De Sevilla, TF .
CLINICAL SCIENCE, 2003, 105 (05) :601-607
[2]   EMPYEMA OF THE THORAX IN ADULTS - ETIOLOGY, MICROBIOLOGIC FINDINGS, AND MANAGEMENT [J].
ALFAGEME, I ;
MUNOZ, F ;
PENA, N ;
UMBRIA, S .
CHEST, 1993, 103 (03) :839-843
[3]   MANAGEMENT OF EMPYEMA THORACIS [J].
ALI, I ;
UNRUH, H .
ANNALS OF THORACIC SURGERY, 1990, 50 (03) :355-359
[4]  
ANDREWS NC, 1962, AM REV RESPIR DIS, V85, P935
[5]  
[Anonymous], 2003, THORAX, DOI DOI 10.1136/THORAX.58.SUPPL_2.II18
[6]   PLEURAL EXUDATES AND TRANSUDATES - DIAGNOSIS WITH CONTRAST-ENHANCED CT [J].
AQUINO, SL ;
WEBB, WR ;
GUSHIKEN, BJ .
RADIOLOGY, 1994, 192 (03) :803-808
[7]   EMPYEMA THORACIC - FACTORS INFLUENCING MORBIDITY AND MORTALITY [J].
ASHBAUGH, DG .
CHEST, 1991, 99 (05) :1162-1165
[8]   Intrapleural urokinase in the treatment of complicated parapneumonic pleural effusions and empyema [J].
Bouros, D ;
Schiza, S ;
Tzanakis, N ;
Drositis, J ;
Siafakas, N .
EUROPEAN RESPIRATORY JOURNAL, 1996, 9 (08) :1656-1659
[9]   Intrapleural urokinase versus normal saline in the treatment of complicated parapneumonic effusions and empyema - A randomized, double-blind study [J].
Bouros, D ;
Schiza, S ;
Tzanakis, N ;
Chalkiadakis, C ;
Drositis, J ;
Siafakas, N .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (01) :37-42
[10]   Intrapleural streptokinase for pleural infection - A step forward in managing pleural effusions? [J].
Bouros, D ;
Antoniou, KM ;
Light, RW .
BMJ-BRITISH MEDICAL JOURNAL, 2006, 332 (7534) :133-134